These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 15212190

  • 1. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T, Kondo R, Miyazaki J, Fukumokto K, Torigoe H.
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
    Horiguchi T, Kondo R, Miyazaki J, Torigoe H, Tachikawa S.
    Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
    Hozawa S, Haruta Y, Terada M, Yamakido M.
    Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G.
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [Abstract] [Full Text] [Related]

  • 8. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
    Gutiérrez V, Prieto L, Torres V, Trenor R, Pérez C, Bertó JM, Marín J.
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
    [Abstract] [Full Text] [Related]

  • 9. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.
    Turk J Pediatr; 2009 Jun; 51(5):460-5. PubMed ID: 20112601
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kume H, Shimokata K.
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [Abstract] [Full Text] [Related]

  • 11. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
    Burioka N, Miyata M, Endo M, Fukuoka Y, Suyama H, Nakazaki H, Igawa K, Shimizu E.
    Chronobiol Int; 2005 Nov; 22(2):383-90. PubMed ID: 16021849
    [Abstract] [Full Text] [Related]

  • 12. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [Abstract] [Full Text] [Related]

  • 13. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
    Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, Hasegawa H, Yoshida S.
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
    [Abstract] [Full Text] [Related]

  • 14. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
    Onadeko BO, Khadadah ME, Mustafa HT, Ezeamuzie CI, Marouf R, Khamis A, Sugathan TN.
    East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
    [Abstract] [Full Text] [Related]

  • 15. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T, Fujisawa T, Nagao M, Akasawa A, Nomura I, Yamaoka A, Kondo H, Masuda K, Yamaguchi K, Terada A, Ikeda M, Nishioka K, Adachi Y, Kurihara K.
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [Abstract] [Full Text] [Related]

  • 16. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R, Grubek-Jaworska H, Hermanowicz-Salomon J, Droszcz W.
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits of induced sputum for the evaluation of therapeutic efficacy in patients with bronchial asthma.
    Ohnishi H, Maeda H, Nishimura Y, Yokoyama M.
    Kobe J Med Sci; 1998 Aug; 44(4):149-61. PubMed ID: 10352494
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.